Cassava Sciences, Inc.
SAVA
$2.05
-$0.07-3.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 13.67M | -42.62M | 17.68M | 972.00K | 16.23M |
| Gross Profit | -13.67M | 42.62M | -17.68M | -972.00K | -16.23M |
| SG&A Expenses | 7.92M | -943.00K | 14.05M | 46.20M | 6.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.59M | 19.59M | 31.72M | 61.40M | 22.93M |
| Operating Income | -21.59M | -19.59M | -31.72M | -61.40M | -22.93M |
| Income Before Tax | -23.40M | -27.60M | -27.94M | 6.16M | 25.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.40M | -27.60M | -27.94M | 6.16M | 25.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.40M | -27.60M | -27.94M | 6.16M | 25.04M |
| EBIT | -21.59M | -19.59M | -31.72M | -61.40M | -22.93M |
| EBITDA | -21.37M | -19.33M | -31.46M | -61.10M | -22.62M |
| EPS Basic | -0.48 | -0.57 | -0.58 | 0.13 | 0.58 |
| Normalized Basic EPS | -0.26 | -0.23 | -0.38 | 0.08 | 0.32 |
| EPS Diluted | -0.48 | -0.57 | -0.58 | 0.13 | -0.43 |
| Normalized Diluted EPS | -0.26 | -0.23 | -0.38 | 0.08 | 0.31 |
| Average Basic Shares Outstanding | 48.26M | 48.10M | 47.98M | 46.20M | 43.00M |
| Average Diluted Shares Outstanding | 48.26M | 48.10M | 47.98M | 46.20M | 44.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |